Setting Up R&D Labs & Testing Facilities in India: Certifications & Compliance

Why Foreign Companies Are Setting Up R&D in India

India has emerged as a global R&D hub, driven by a combination of skilled talent, cost advantages, and increasingly robust government incentives. The Union Budget 2025-26 allocated INR 20,000 crore specifically for private sector-driven research and development. Production Linked Incentive (PLI) schemes across 14 strategic sectors have catalysed over INR 2 lakh crore in investments, with many PLI beneficiaries establishing dedicated R&D and testing facilities to support their manufacturing operations.

For foreign companies — whether pharmaceutical firms needing clinical trial support, electronics manufacturers requiring product testing, or technology companies building innovation centres — understanding the certification and compliance landscape is essential before committing capital. The regulatory framework spans multiple central and state authorities, each with specific requirements for different types of research and testing activities.

India now hosts over 2,000 Global Capability Centres, many of which include R&D functions. Patent filings from India have surged between 2020 and 2025, directly correlating with increased PLI-driven R&D investments. This guide covers the complete setup process — from entity structure through DSIR recognition and NABL accreditation to ongoing compliance.

Types of R&D and Testing Facilities

The regulatory requirements vary significantly based on the type of facility you plan to establish. Understanding the classification upfront determines which certifications, approvals, and compliance obligations apply.

In-House R&D Units

These are R&D centres operated by a company for its own research purposes — developing new products, processes, or technologies related to the company's business. In-house R&D units qualify for DSIR recognition and Section 35(2AB) tax benefits. Most foreign companies establishing R&D operations in India fall into this category, whether they are pharmaceutical companies, automotive manufacturers, or electronics firms.

Contract Research and Testing Laboratories

Independent laboratories that provide testing, calibration, or research services to external clients. These facilities require NABL accreditation (under ISO/IEC 17025 for testing and calibration labs) to operate credibly and, in many sectors, legally. Pharmaceutical testing labs may additionally need approval from the Central Drugs Standard Control Organisation (CDSCO), while food testing labs require FSSAI notification.

Clinical Research Facilities

Facilities conducting clinical trials for pharmaceutical or biotech companies require approvals from the Central Drugs Standard Control Organisation (CDSCO), registration with the Clinical Trials Registry-India (CTRI), Institutional Ethics Committee (IEC) approval, and compliance with the New Drugs and Clinical Trials Rules, 2019. Clinical research is a specialised subset that warrants dedicated regulatory guidance beyond this article's scope.

DSIR Recognition: The Foundation for R&D Tax Benefits

The Department of Scientific and Industrial Research (DSIR) is the nodal government department for recognising in-house R&D units. DSIR recognition is the prerequisite for claiming weighted tax deductions under Section 35(2AB) of the Income Tax Act — making it the single most important certification for any foreign company establishing an R&D facility in India.

Eligibility Criteria for DSIR Recognition

• The company must be registered under the Companies Act, 2013 (a private limited company, public company, or Section 8 company)
• The R&D unit must be engaged in research and development related to the company's business activities
• The R&D facility must be a separate, identifiable unit with dedicated space, equipment, and personnel
• The company must have a minimum of three full-time R&D staff with relevant scientific or technical qualifications
• The R&D unit must maintain separate accounts for R&D expenditure

Eligible Sectors

DSIR recognition and Section 35(2AB) benefits are available for in-house R&D units in the following sectors: chemicals, drugs and pharmaceuticals (including clinical trials and regulatory approvals), biotechnology, electronic equipment, computers and telecommunications equipment, and aircraft and aerospace. Companies outside these sectors can still seek DSIR recognition but may not qualify for the weighted deduction under Section 35(2AB) — they can claim the standard 100% deduction under Section 35(1).

Application Process

Updated guidelines and application formats were released by DSIR on 15 July 2025. The application must be submitted digitally — no hard copies are required. The submission includes a covering letter and fully completed application form signed by the Managing Director or Director, along with requisite annexures in a single PDF attachment (under 20 MB).

DSIR Application Documentation

The DSIR recognition process typically takes 3-6 months from application submission. Recognition, once granted, is valid for a defined period and must be renewed. As of March 2026, DSIR has flagged renewals of recognition for in-house R&D units beyond 31 March 2026 — companies with expiring recognitions should initiate renewal applications well in advance.

Section 35(2AB): The R&D Tax Deduction

Section 35(2AB) of the Income Tax Act allows companies with DSIR-approved in-house R&D facilities to claim a weighted tax deduction on R&D expenditure. The deduction rate has evolved over the years.

Deduction Rate History

While the weighted deduction has been reduced to 100% (effectively a straight deduction of actual R&D costs), the benefit remains significant because it allows companies to claim the full R&D expenditure as a deduction in the year incurred, regardless of the capitalisation requirements that might otherwise apply under accounting standards.

Eligible R&D Expenditure

• Revenue expenditure: Salaries of R&D personnel, consumables, raw materials for experiments, utility costs attributable to R&D, travel for R&D purposes
• Capital expenditure: Purchase of equipment and machinery used exclusively for R&D, laboratory construction or modification costs
• Excluded: Cost of land and building (other than construction costs), expenditure on clinical trials conducted outside India, expenditure not approved by DSIR in Form 3CL

Form 3CL Certification

DSIR issues Form 3CL certifying the amount of expenditure eligible for the weighted deduction for each financial year. The tax authorities rely on Form 3CL to verify and quantify the deduction. However, the Income Tax Appellate Tribunal (ITAT) has held that non-filing of Form 3CL alone cannot be grounds to deny the deduction if the R&D activity is duly approved by DSIR and is related to the company's business. Despite this ruling, obtaining Form 3CL is strongly recommended to avoid assessment disputes.

NABL Accreditation for Testing Laboratories

The National Accreditation Board for Testing and Calibration Laboratories (NABL) is the autonomous accreditation body under the Department for Promotion of Industry and Internal Trade (DPIIT). NABL accreditation certifies that a laboratory operates according to ISO/IEC 17025 (for testing and calibration) or ISO 15189 (for medical testing) — internationally recognised standards for laboratory competence.

Why NABL Accreditation Matters

NABL accreditation is not merely a quality badge — it is a regulatory requirement in several contexts. FSSAI mandates NABL-accredited labs for official food testing. BIS requires NABL-accredited labs for product certification testing. Environmental monitoring must be conducted by NABL-accredited laboratories. State Pollution Control Boards require NABL-accredited labs for effluent and emission testing. Export certification in many sectors requires test reports from NABL-accredited facilities.

NABL Accreditation Process

1. Gap analysis (Months 1-2): Assess current laboratory management system against ISO/IEC 17025 requirements. Identify gaps in documentation, personnel competence, equipment calibration, and quality management.
2. System implementation (Months 2-4): Develop and implement the Quality Management System (QMS), including quality manual, standard operating procedures (SOPs), test methods, and calibration procedures. Train all personnel.
3. Internal audit (Month 4): Conduct internal audit to verify QMS compliance. Address non-conformities.
4. Application submission (Month 5): Submit NABL accreditation application with all required documentation, including QMS documents, equipment list, personnel qualifications, and proficiency testing results.
5. Document review (Months 5-6): NABL reviewers assess the documentation package. Clarifications and corrections may be requested.
6. On-site assessment (Month 6-7): NABL assessors visit the laboratory to evaluate equipment, observe test procedures, review records, and interview personnel.
7. Corrective actions (Month 7-8): Address any non-conformities identified during assessment.
8. Accreditation decision (Month 8-9): NABL Accreditation Committee reviews assessment report and grants accreditation.

The total timeline is typically 6-9 months, though well-prepared laboratories can complete the process in as little as 3-4 months. NABL accreditation is valid for 2 years initially, with subsequent renewals for 4-year cycles.

NABL Accreditation Costs

Environmental and Safety Compliance

R&D and testing facilities must comply with India's environmental and safety regulatory framework. The requirements vary based on the nature of research activities — a software R&D lab has minimal environmental obligations, while a pharmaceutical or chemical testing facility faces comprehensive requirements.

Environmental Clearances

The Ministry of Environment, Forests and Climate Change (MoEFCC) categorises industries into four categories based on pollution index scores: Red (highly polluting), Orange (moderately polluting), Green (low pollution), and White (non-polluting). R&D labs handling hazardous chemicals, biological agents, or generating significant waste typically fall into the Orange or Red categories.

Key environmental permits include Consent to Establish (CTE) from the State Pollution Control Board (SPCB) — required before construction begins, Consent to Operate (CTO) from the SPCB — required before commencing operations and renewed annually, Hazardous Waste Authorisation under the Hazardous and Other Wastes (Management and Transboundary Movement) Rules, 2016, and Environmental Impact Assessment (EIA) for larger facilities (typically only required for facilities exceeding specified production thresholds).

The PARIVESH 2.0 platform digitises the environmental clearance process. All applications for CTE, CTO, and environmental clearance can be submitted online, with real-time tracking of application status. The EIA regulations updated through 2025 incorporate climate change assessment requirements, mandating projects to assess carbon emissions impact.

Laboratory Safety Requirements

• Factories Act, 1948: Applicable if the lab is classified as a factory (employing 10+ workers with power or 20+ without). Requires registration as a factory, occupier registration, and periodic safety inspections.
• Chemical safety: Manufacture, Storage and Import of Hazardous Chemical Rules, 1989, govern the handling of hazardous chemicals. Labs importing chemicals in quantities exceeding 1 tonne per year must notify the National Chemical Authority under India's evolving chemicals regulation framework.
• Biological safety: Institutional Biosafety Committee (IBSC) approval is required for labs working with genetically modified organisms or recombinant DNA. Registration with the Review Committee on Genetic Manipulation (RCGM) may be necessary for certain categories of research.
• Radiation safety: Labs using radioactive materials or radiation-generating equipment require a licence from the Atomic Energy Regulatory Board (AERB).
• Fire safety: Fire NOC from the local fire department, compliant fire detection and suppression systems, and periodic fire drills.

BIS Certification for Product Testing Labs

The Bureau of Indian Standards (BIS) operates a Compulsory Registration Scheme (CRS) that mandates BIS certification for over 450 product categories sold in India. Foreign companies establishing testing facilities in India to support their product certification process must understand the BIS framework.

Key recent developments include the regulatory shift in December 2025 where FSSAI scrapped the mandatory BIS mark for packaged drinking water while introducing a stricter scheme of testing effective January 2026 — requiring all testing through FSSAI-notified NABL-accredited laboratories.

BIS Lab Recognition Requirements

Laboratories seeking BIS recognition must be NABL accredited to ISO/IEC 17025, have the testing scope covering the relevant Indian Standards (IS) for the products being tested, maintain adequate test equipment with valid calibration certificates, and employ qualified technical personnel with relevant experience. BIS conducts its own assessment of the laboratory in addition to NABL accreditation, focusing on the lab's capability to test against specific Indian Standards.

Step-by-Step Setup Guide for Foreign Companies

Phase 1: Entity and Structure (Months 1-3)

• Incorporate Indian entity — typically a wholly owned subsidiary as a private limited company via SPICe+
• File FC-GPR with RBI for share allotment to foreign parent within 30 days
• R&D qualifies under the automatic route for FDI in most sectors — no prior government approval needed
• Obtain PAN, TAN, and GST registration
• Open corporate bank account
• Appoint resident director (mandatory — must have stayed 182+ days in India)

Phase 2: Facility Setup (Months 2-6)

• Identify suitable premises — R&D labs may be located in IT parks, industrial parks, or standalone facilities
• Obtain Consent to Establish (CTE) from SPCB if handling hazardous materials
• Execute lease agreement and register if term exceeds 11 months
• Design and build out laboratory space to relevant safety and quality standards
• Procure and install laboratory equipment — import duties exempt if in STPI/SEZ, otherwise standard customs duties apply (equipment for R&D eligible for concessional duty under specific notifications)
• Obtain fire safety NOC and electrical safety certification

Phase 3: Certifications (Months 4-12)

• Apply for DSIR recognition — 3-6 months processing time
• Implement ISO/IEC 17025 Quality Management System if seeking NABL accreditation
• Conduct proficiency testing rounds (mandatory for NABL)
• Submit NABL application and complete on-site assessment — total 6-9 months
• Obtain Consent to Operate (CTO) from SPCB before commencing operations
• Register as factory under the Factories Act if applicable

Phase 4: Ongoing Compliance (Continuous)

• File FLA Return with RBI by 15 July each year
• Maintain R&D expenditure records for DSIR annual reporting
• Submit Form 3CL application to DSIR annually for tax deduction certification
• NABL surveillance assessments (annual for first cycle, then as scheduled)
• CTO renewal from SPCB annually
• Annual compliance filings — ROC returns, tax returns, transfer pricing documentation if R&D services are provided to the parent company

PLI Scheme Synergy with R&D Facilities

India's Production Linked Incentive schemes across 14 sectors have created a natural incentive for foreign companies to establish R&D and testing facilities alongside or in support of manufacturing operations. As of July 2025, 806 applications have been approved across all PLI sectors, with electronics production growing from INR 1.9 lakh crore in FY 2014-15 to INR 11.3 lakh crore in FY 2024-25.

The March 2025 Cabinet approval of a INR 22,919 crore PLI scheme for non-semiconductor electronics components — targeting PCBs, display modules, camera modules, lithium-ion cells, and passive components — directly necessitates R&D and testing infrastructure for quality assurance, product development, and compliance verification.

For foreign companies already participating in PLI schemes or considering PLI-linked investments, co-locating R&D and testing facilities with manufacturing operations provides cost efficiencies in facility management, shared infrastructure for product development and quality testing, streamlined compliance across DSIR, NABL, and BIS certifications, and combined tax benefits from both PLI incentives and R&D deductions.

Patent Filing and IP Protection

Foreign companies establishing R&D in India should integrate intellectual property protection into their facility setup from day one. India's patent filing landscape is growing rapidly — patent filings surged between 2020 and 2025, correlating with PLI-driven R&D investments.

Key IP-related considerations for R&D facilities include ensuring employment contracts contain robust IP assignment clauses under Indian law, filing patent applications with the Indian Patent Office (4 offices: Delhi, Mumbai, Kolkata, Chennai), leveraging the MSME patent fee structure if your Indian subsidiary qualifies (filing fee reductions of up to 80% for small entities), and maintaining lab notebooks and documentation standards that support patent prosecution.

Government support for patent filing includes reimbursement up to INR 1 lakh for Indian patents and up to INR 5 lakh for foreign patents for MSMEs. BIRAC (Biotechnology Industry Research Assistance Council) provides additional support for biotech R&D and patent costs.

Key Takeaways

• DSIR recognition is the prerequisite for R&D tax benefits — apply early in the facility setup process since recognition takes 3-6 months, and the Section 35(2AB) deduction only applies from the date of DSIR approval
• NABL accreditation is mandatory, not optional — for testing labs serving external clients, regulatory testing, or export certification, NABL accreditation to ISO/IEC 17025 is a legal and commercial requirement
• Environmental compliance varies by facility type — software R&D labs face minimal requirements, while chemical, pharmaceutical, or biological facilities need CTE/CTO from SPCB, hazardous waste authorisation, and potentially EIA clearance
• Plan 12-18 months from entity setup to fully operational, certified R&D lab — the overlap between facility construction, equipment procurement, and certification processes requires careful project management
• Integrate IP protection from day one — employment contracts, patent filing strategies, and documentation standards should be established before R&D operations commence, not after

Setting up an R&D facility in India offers significant strategic advantages — from cost-competitive talent to government incentives — but requires navigating a multi-layered regulatory framework. Our company incorporation services handle the entity setup phase, while our annual compliance team ensures ongoing regulatory filings remain current. For FDI-specific guidance on R&D investments, consult our FDI advisory practice.